Sygnature Discovery
Type:
Screening( in vitro screens)
Pre-Clinical( DMPK, Med Chem, Animal Testing)
Fragment-based Drug Discovery
Arrays & Libraries
Description: Sygnature offers a comprehensive range of premium integrated drug discovery services to pharmaceutical and biotechnology companies located in North America and Europe.
In-house expertise includes:
Medicinal chemistry
Bioscience (in vitro biology and screening)
Computational chemistry
Fragment-based drug discovery
Arrays and libraries
Process and scale-up chemistry
City: Nottingham
State:
Contact Person: Paul Clewlow
Contact email: p.clewlow@sygnaturediscovery.com
